Aki India Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
AKI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AKI India reported a sharp divergence between its standalone and consolidated numbers for Q3 FY26 and 9M FY26. On a standalone basis, Q3 net sales fell sharply to ₹1,329.50 lakhs from ₹2,174.81 lakhs a year earlier (~39% decline), with PAT dropping to ₹18.93 lakhs from ₹66.97 lakhs and EPS at ₹0.02 vs ₹0.08. For 9M FY26 standalone, net sales declined to ₹4,303.87 lakhs (~17% lower) and PAT fell to ₹86.01 lakhs from ₹150.93 lakhs. However, on a consolidated basis (including subsidiary AKI UK Limited and joint venture AKI Castil Shoes LLP), 9M FY26 net sales grew to ₹7,074.88 lakhs from ₹5,694.18 lakhs (~24% growth) and PAT jumped to ₹210.00 lakhs from ₹154.42 lakhs (~36% growth), with EPS rising to ₹0.20 from ₹0.17. Standalone operating margins compressed meaningfully, while consolidated margins held broadly steady. The prior-year 9M figures included a positive exceptional/extraordinary item of ₹82.64 lakhs. Statutory auditor R K Parmarthi & Co. issued a clean limited review report with no qualifications or emphasis of matter.
Mixed bag for shareholders: standalone leather business is clearly under pressure with falling revenue and profits, but consolidated growth from subsidiaries/JV is strong, lifting overall earnings. Short-term stock reaction could be cautious given the steep standalone Q3 decline, though the consolidated growth story may support valuation if subsidiary momentum continues.